) or risk factors (diabetes, hypertension) remains unclear. Recently published treatment guidelines for
lipid-lowering therapy suggest the use of statins should be
considered in all individuals with an estimated 10-year risk of

major cardiovascular events >7.5%.58 This would seem to
include any individual with established PAD.6,50 Notably,
the recommended risk estimation algorithm does not
include evidence of PAD or the ABI value.58
Exercise and limb